ExcelVite says that its new vitamin E ingredient is the only non-soy, non-GMO, allergen-free vitamin E on the market to contain all eight vitamin E isoforms.
Photo © iStockphoto.com/timsa
Palm tocotrienol, carotene, and palm oil supplier ExcelVite Inc. (Edison, NJ) is launching what it says is the only non-soy, non-GMO, allergen-free vitamin E ingredient on the market to contain all eight vitamin E isoforms-that is, all four tocopherols and four tocotrienols that comprise vitamin E. According to a company representative, EVNol-RP (the liquid version of the ingredient) and EVNolMax-RP (the powder form of the ingredient) answer increased consumer demand for clean-label, allergen-free ingredients.
Vitamin E comprises eight distinct compounds-four tocopherols and four tocotrienols-that make up the complete vitamin. These compounds include alpha-, beta-, gamma-, and delta-tocopherols, and alpha-, beta-, gamma-, and delta-tocotrienols. While other companies offer full-spectrum vitamin E ingredients, ExcelVite says that its vitamin E is the only full-spectrum vitamin E that is also non-GMO and soy-free.
While most vitamin E in the market is derived from soybean oil, vitamin E can also be derived from alternative sources like sunflowers or corn. It can also be manufactured naturally or synthetically. According to ExcelVite, both the liquid and powder forms of its proprietary vitamin E ingredient are derived from natural vegetable oils, and are naturally, not synthetically, manufactured.
In a press release from the company, Bryan See, business development manager, ExcelVite, also commented on the impending Nutrition Facts labelling requirements for vitamin E content. Under the new label requirements, all vitamin E content must be declared in milligrams (mg) instead of in international units (IU) by January 1st, 2010. Said See: “It would be a great opportunity for dietary supplement manufacturers and our clients to formulate this new concept of vitamin E complete, or reformulate existing vitamin E with EVNol-RP and EVNolMax-RP to keep up with the science and regulatory requirements.”
He continued: We are on the cusp of the new era of vitamin E, what I’d call [the] ‘non-IU era’ of vitamin E supplements. We are here to assist manufacturers who want to formulate new vitamin E products with full spectrum vitamin E that meet the clean-label product trend and comply with FDA’s rules.”
See also pointed to the growing body of research buoying vitamin E’s potential in the brain- and cognitive-heath markets. He cited clinical research conducted in several European cohort studies showing that vitamin E may help protect the elderly from mild cognitive impairment and potentially reduce the risk for Alzheimer’s disease. “This will be another plus point for formulators to add to their product labels as brain-health or cognitive-support benefits to the consumers,” said See.
Both vitamin E ingredients are now available to manufacturers worldwide.
Also read:
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.